Subscribe Now
Forgot Password?

Weekly News, Analysis, and Commentary

Company News Feature

(L to R): Mike Lobinsky and Pierre Schwich / Courtesy of EOS imaging and

Mike Lobinsky, Pierre Schwich Now at EOS imaging

Elizabeth Hofheinz, M.P.H., M.Ed. • Thu, August 17th, 2017

Print this article

Mike Lobinsky and Pierre Schwich have come on board at Paris, France-based EOS imaging, with Lobinsky taking on the position of President, North America and Schwich assuming the position of chief financial officer (CFO).

The company wrote in its July 18, 2017 news release, “Lobinsky has formerly served as U.S. Vice President, Sales and Implementation – Robotics at Smith & Nephew, which he joined through their 2016 acquisition of Blue Belt Technologies, a global leader in surgical robotics. At Blue Belt, he served as Vice President, Sales, leading all sales related activities for the company’s Navio surgical system, which provides robotics-assistance in knee replacement surgery. From 2006 to 2013, Lobinsky served in roles of increasing responsibly at BioMedix Vascular Solution, most recently as Vice President, Sales and Marketing.”

“Pierre Schwich brings over 20 years of experience in Financial Management at high growth, public and private companies in the healthcare and technology sectors. Before joining EOS imaging, he was CFO of Pharnext, where he successfully led the company’s initial public offering. He was previously Financial and Legal Director of Oceasoft, a company specialized in connected sensors, and CFO of Cellectis where he contributed to a private placement with U.S. investors. Pierre was also Deputy CEO, in charge of finances, of Genesys Conferencing, a public company listed in Paris and on the NASDAQ, with a strong activity in the U.S.”

Pierre Schwich told OTW, “I am very excited to join EOS imaging at a stage when the company has already proven its uniqueness in imaging solutions for musculoskeletal pathologies through its technology platform. The company, listed on Euronext since 2012, also benefits from a highly professional governance with appropriate quality and compliance rules.”

“Over the coming weeks, I will complete my full understanding of the development, manufacturing and selling processes to further secure them and contribute to their improvement. I will also be focused on investor relations in order to increase our awareness within the financial community and gain interest from European and American investors. I am convinced of the exceptional potential of EOS imaging, and my role beyond the first six months will be to ensure the company has the financial organization and means to support its fast development.”

Mike Lobinsky commented to OTW, “I have always been impressed with the EOS technology and what the company has accomplished. It’s an exciting time to come on board. We are experiencing rapid growth in North America as EOS is the standard of care for hospitals that prioritize safe imaging and patient-specific treatments. To ensure that we have the staff to address the needs of our current and future customers, one of my main focuses will be to grow our North American applications, service, and sales teams. This will help us continue to deliver the high level of service our customers are used to receiving as well as drive the adoption of our advanced orthopedic solutions for the spine, hip, and knee.”

Send to a Friend

The article link will be sent to the email address you provide

Your Name (required)

Your Email (required)

Friend's Email (required)


Leave a Reply


Email Address (will not be published)